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Nur77 (NR4A1) belongs to the NR4A subfamily of nuclear
orphan receptors that comprise of Nur77 (NR4A1), Nurr1
(NR4A2) and Nor-1 (NR4A3) and that act as stimulus-
induced transcriptional activators in many tissues including
skeletal and cardiac muscle, T-cells, liver and brain (reviewed
in Maxwell and Muscat 2006). Since its discovery as a gene
induced by nerve growth factor in PC12 cells (Milbrandt
1988; Yoon and Lau 1993), Nur77 expression has been
documented in neurons and neuronal cell lines where it is
induced by growth factors (Kendall et al. 1994; Dickey et al.
2004) and synaptic activity (Shalizi et al. 2006; Zhang et al.
2007). Recent work has shown that activity-dependent
changes in Nur77 expression play an important role in the
dendritic development of cerebellar granule neurons where
repression of Nur77 is required for synapse formation
(Shalizi et al. 2006).
In PC12 cells Nur77 expression is induced by membrane
depolarization through increases in intracellular Ca2+ and the
subsequent activation of Ca2+/calmodulin dependent protein
kinases and the Ca2+/calmodulin-activated phosphatase cal-
cineurin (Yoon and Lau 1993, 1994; Enslen and Soderling
1994) and does not require activation of the MAPK
signalling pathway (Machado et al. 2008). Two Ca2+-
activated transcription factors that are downstream targets
of calcineurin and calmodulin dependent protein kinases and
that have been shown to regulate Nur77 expression are the
basic leucine zipper containing transcription factor cAMP
response element binding protein (CREB) and myocyte
enhancer factor-2 (MEF2), which belongs to the MCM1-
Agamous-Deﬁciens-SRF (MADS) box family of transcrip-
tion factors. The Nur77 gene contains four copies of a CRE
that binds CREB and two binding sites for MEF2 factors.
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Abstract
Expression of the nuclear orphan receptor gene Nur77 in
neuronal cells is induced by activity-dependent increases in
intracellular Ca2+ ions. Ca2+ responsiveness of the Nur77
gene has been attributed to two distinct DNA regulatory re-
gions that recruit the transcription factors cAMP response
element binding protein (CREB) and myocyte enhancer fac-
tor-2 (MEF2). Here we used dominant interfering and consti-
tutively active mutants of CREB and MEF2 proteins to assess
their relative contribution to depolarization-induced Nur77
expression in undifferentiated PC12 cells and hippocampal
neurons. We show that while CREB is necessary for Ca2+-
activated Nur77 expression MEF2 functions to modulate
CREB-dependent Nur77 expression by acting as a repressor
in quiescent cells.
Keywords: cAMP response element binding protein, myo-
cyte enhancer factor-2, neurons, Nur77, PC12 cells, Tran-
scriptional Regulation.
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The Nur77 CREs (TGCGTCA) diverge from the consensus
CRE sequence of TGACGTCA and have previously been
deﬁned as AP1 (activator protein 1) elements (Yoon and Lau
1993). Early work by Yoon and Lau (1994) in fact implicated
JunD, and not CREB, in mediating Nur77 transcription
through these AP1-like elements. More recently, Fass et al.
(2003) identiﬁed Nur77 as a CREB target gene in PC12 cells
by expressing a constitutively active mutant of CREB and
screening for genes whose expression was up-regulated.
CREB occupancy of the Nur77 promoter was further
conﬁrmed by serial analysis of chromatin occupancy using
an antibody against CREB to immunoprecipitate chromatin
(Impey et al. 2004). The MEF2 response elements (MRE) of
the Nur77 gene were ﬁrst identiﬁed as Ca2+-responsive
elements in T-cells where the MEF2 sites are required for
optimal Nur77 induction by Ca2+-mobilizing stimuli (Wo-
ronicz et al. 1995). Recently, Shalizi et al. (2006) used
chromatin immunoprecipitation assays to show that the
Nur77 promoter was also occupied by MEF2 proteins in
neurons. Furthermore, a dominant repressor form of MEF2A
repressed expression of a luciferase reporter gene driven by
the MEF2 binding sites of Nur77 suggesting that MEF2
proteins may be important for Nur77 expression. However,
early work done in PC12 cells showed that deletion of the
MRE containing region of the Nur77 gene did not affect its
expression following membrane depolarization, suggesting
that the MREs are not essential for Ca2+-induced Nur77
expression in these cells (Yoon and Lau 1993). As Shalizi
et al. (2006) tested the effects of engineered MEF2 repressors
on a reporter gene that is driven only by the Nur77 MREs, it
raises questions about the contribution of MEF2 proteins to
Ca2+-activated Nur77 expression in neurons and neuronal cell
lines. To resolve this, here we assessed the effects of MEF2
and CREB dominant interfering and constitutively active
mutants on Ca2+-activated expression of a Nur77 reporter
gene driven by both the MREs and CREs.
Experimental procedures
Plasmids
The MEF2 dominant negative construct (MEF2DN) encoding the
myc-tagged conserved MADS-box/MEF2 domain of MEF2D was
constructed by cloning a PCR ampliﬁed fragment of MEF2D
corresponding to amino acids 1–87 between the Kpn1 and BamH1
sites of pcDNA3.1-myc-His (Invitrogen, Carlsbad, CA, USA).
Constitutively active MEF2 was generated by cloning the transcrip-
tional activation domain of VP16 (ampliﬁed from plasmid
Gal4VP16) into the MEF2DN plasmid between the BamH1 and
Not1 sites. The expression plasmid for dominant negative A-CREB
was a gift from Prof. David Ginty (The John Hopkins School of
Medicine, Baltimore, MD, USA). VP16CREB expression vector
(Zhang and Bading, unpublished data) was kindly provided by Prof.
Hilmar Bading (University of Heidelberg, Germany). The Nur77
luciferase reporter constructs )1800Nur77Luc, )250Nur77Luc and
)316/)252Nur77Luc have been described in Blaeser et al. (2000)
and were kindly provided by Prof. Talal Chatila (UCLA, CA).
phRL-SV40 expressing Renilla luciferase was from Promega
(Madison, WI, USA). Plasmid MEF2-EN, expressing MEF2-
engrailed fusion protein, was provided by Prof. Ilona Skerjanc
(University of Ottawa, Canada) and MEF2DK439A was provided
by Dr Xiang-Jiao Yang (McGill University Health Center, Montreal,
Canada). The expression plasmid encoding green ﬂuorescent protein
(GFP) coupled-nuclear factor of activated T-cells (NFAT4)
(pcDNA3-GFP-NFAT4) was kindly provided by Prof. Frank
McKeon (Harvard Medical School, MA, USA) and the NFAT
inhibitor GFP-VIVIT (Aramburu et al. 1999) was obtained from
Prof. Anjana Rao (Harvard Medical School, MA, USA).
Cell culture and luciferase assays
PC12 cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
containing GlutaMAX I, 4.5 g/L glucose and 110 mg/L pyruvate
(Invitrogen), 100 U/mL penicillin, 100 lg/mL streptomycin (Invi-
trogen) supplemented with 10% heat-inactivated horse serum
(Invitrogen) and 5% fetal calf serum (PAA Lab, Pasching, Austria).
Hippocampal neurons were cultured and transfected as described in
Lam et al. (2009). PC12 cells and hippocampal neurons cultured in
12-well poly-D-lysine coated plates were transfected with the
indicated plasmids using Lipofectamine 2000 (Invitrogen). Thirty-
six hours after transfection cells were either left untreated or
stimulated for 6 h as indicated and then subjected to luciferase
assays as described previously (Belﬁeld et al. 2006) using the
Promega Dual Glo assay kit (Promega). Fireﬂy luciferase activity
was normalized to the Renilla luciferase signal and all measure-
ments were made in duplicate.
Immunoblotting
For western blots total proteins were extracted by lyzing cells with
radio immunoprecipitation assay (RIPA) buffer containing 50 mM
Tris, 150 mM NaCl, 1 mM EDTA, 1% Sodium deoxycholate, 1%
Triton X100, 0.1% sodium dodecyl sulfate (SDS) and protease
inhibitor cocktail (Calbiochem, Merck, Darmstadt, Germany).
Protein concentration was determined using protein assay DC kit
(Bio-Rad, Hercules, CA, USA) according to the manufacturer’s
instruction. Fifty lg protein lysate was loaded onto a pre-cast 12%
Novex Tris–glycine polyacrylamide gel (Invitrogen) followed by
electrophoretic separation at 150 V for 1.5 h in buffer containing
25 mM Tris, 192 mM glycine and 0.1% SDS. The proteins were
then transferred to polyvinylidene diﬂuoride membrane at 30 V for
2.5 h at 4C in transfer buffer containing 25 mM Tris, 192 mM
glycine, 0.1% SDS and 20% methanol. The polyvinylidene
diﬂuoride membrane was incubated with blocking buffer containing
5% skimmed milk in Tris buffered saline with Tween (TBST) for
1 h, followed by incubation with primary antibody diluted in
blocking buffer overnight at 4C. The following antibodies were
used at the indicated dilutions: MEF2D speciﬁc antibody (BD
Pharmingen, Franklin Lakes, NJ, USA) at 1 : 2000; phospho-CREB
at 1 : 5000 (Upstate, Lake Placid, NY, USA); b-actin at 1 : 10 000
(Sigma, St Louis, MO, USA). After removal of primary antibody,
the membrane was rinsed three times (10 min each) and incubated
with horseradish peroxidase (HRP) conjugated secondary antibodies
(DAKO, Glostrup, Denmark) at 1 : 1000 dilution for 1 h at 25C.
The membranes were then washed three times (10 min each) and the
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bands were visualized using ECL detection kit (Amersham, Little
Chafont, Buckinghamshire, UK).
NFAT localization
To assess NFAT localization PC12 cells grown on 13 mm coverslips
were transfected with an expression plasmid encoding GFP-NFAT4.
Twenty-four hours after transfection cells were stimulated with
50 mM KCl for 45 min or left untreated. Cells were ﬁxed in 3%
paraformaldehyde in phosphate-buffered saline (PBS) containing 4%
sucrose as described earlier (Lam and Chawla 2007). Cells were then
washed twice with 10 mM glycine in PBS for 10 min, and counter-
stained with Hoechst 33342 (1 lg/mL in PBS; Invitrogen) for 5 min
to visualize nuclei. Cells were washed twice in with PBS to remove
excess Hoechst dye andmounted in Vectashield (Vector Laboratories,
Burlingame, CA, USA). GFP and Hoechst ﬂuorescence was detected
using an inverted Leica TCS SP5 confocal system (Leica Microsys-
tems, Wetzlar, Germany) and a 20· water immersion objective lens.
Results
We used a luciferase reporter construct that contains the
ﬁreﬂy luciferase gene downstream of rat Nur77 genomic
DNA from )1800 to +119 bp relative to the transcription
start site. Figure 1(a) shows the 2 MEF2 response elements
(MREs) located at )309 and )275 bp upstream of the
transcriptional start site and the four CREs at positions )235,
)215, )71 and )42 bp relative to the transcription start site
of the rat gene. The sequences are conserved in human and
mouse genes. We ﬁrst established that constitutively active
mutants of CREB and MEF2 could activate the )1800Nur77
luciferase reporter gene (Fig. 1b). Co-expression of
MEF2VP16, which encodes the MADS/MEF2 domain of
mouse MEF2D (amino acids 1–87) fused to the transcrip-
tional activation domain of VP16, potentiated )1800Nur77-
Luc expression by 45.70 ± 5.38-fold relative to cells
transfected with vector control. Similar to constitutively
active MEF2, VP16CREB that encodes a fusion protein
comprising of the VP16 activation domain and rat CREB,
was also a potent activator of Nur77 expression and caused a
66.30 ± 3.16-fold increase in )1800Nur77Luc expression.
This is consistent with earlier work that reported an increase
in Nur77 mRNA levels by VP16CREB expression in PC12
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Fig. 1 The promoter of the Nur77 gene recruits CREB and MEF2
transcription factors. (a) Schematic representation of the rat Nur77
promoter region within the )1800Nur77 firefly luciferase reporter
plasmid. There are four CREs at )42, )71, )215 and )235 bp up-
stream of the transcriptional start site (TSS). Two MREs are located at
)275 and )309 bp from the TSS. The CREB and MEF2 binding sites
are conserved between rat, mouse and human genes. (b) Constitu-
tively active VP16CREB and MEF2VP16 proteins activate Nur77
transcription by binding to the corresponding CREs and MREs on the
promoter. PC12 cells grown on 12-well cell culture plates were
transfected with either 1 lg VP16CREB or 1 lg MEF2VP16, 500 ng of
the indicated Nur77 firefly luciferase reporter plasmid ()1800Nur77Luc
reporter containing the MREs and CREs, or the )316/)252Nur77Luc
reporter containing only the MREs or the )250Nur77Luc reporter
containing only the CREs), and 50 ng phRL-SV40 expressing renilla
luciferase. Thirty-six hours after transfection, cells were lysed with
passive lysis buffer and subjected to luciferase assays. Firefly lucif-
erase activity was normalized to renilla luciferase activity. The
mean ± SEM of relative luciferase activity is shown in the graph, data
were generated from four independent transfection experiments.
p < 0.05 (one-way ANOVA followed by Bonfferroni’s post-hoc test).
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cells (Fass et al. 2003). The effects of VP16CREB and
MEF2VP16 were mediated speciﬁcally by their respective
DNA binding regions of the Nur77 gene as a construct
containing )316 to )252 bp of 5¢ regulatory sequences,
which encompasses the two MREs but lacks the CREs, was
activated by MEF2VP16 only and a truncated construct
containing )250 bp of the promoter that lacks the MREs was
activated only by VP16CREB (Fig. 1b).
We next tested the effect of dominant negative CREB and
MEF2 constructs on Nur77 induction by depolarization in
PC12 cells. Membrane depolarization of PC12 cells with
50 mM extracellular KCl induced rapid activation of CREB
phosphorylation on serine 133 that is necessary for CREB-
mediated gene expression (Fig. 2a). Depolarization also
caused a robust increase (5.38 ± 0.51-fold) in the expression
of )1800Nur77 luciferase reporter gene (Fig. 2b). To assess
the contribution of CREB to Nur77 induction by depolar-
ization we interfered with CREB function by expressing A-
CREB, which is an inhibitory form of CREB protein that is
deﬁcient in DNA binding but able to heterodimerize with
CREB and related transcription factors such as ATF1 and
cAMP responsive element modulator. A-CREB expression
thus interferes with DNA binding of endogenous CREB to
CREs and inhibits CREB-dependent gene expression in
PC12 cells (Ahn et al. 1998). A-CREB inhibited induction of
)1800Nur77 luciferase by depolarization and also attenuated
basal expression of the Nur77 reporter gene (Fig. 2b). To
assess the contribution of MEF2 factors to Nur77 expression
we expressed a dominant negative MEF2 protein, MEF2DN
that encodes the MADS/MEF2 DNA binding domain of
MEF2D and lacks the C-terminal region that contains the
transactivation domain. The MADS/MEF2 domain is con-
served amongst the four MEF2 family members MEF2A,
MEF2B, MEF2C and MEF2D, and recruits transcriptional
repressors such as Cabin1/Cain, Class IIa histone deacety-
lases (HDACs) and MEF2-interacting transcriptional repres-
sor (MITR) (Kim et al. 2005 and references therein) that
dissociate from MEF2 proteins during their Ca2+-dependent
activation. Expression of the MADS/MEF2 domain of
MEF2A has been shown previously to act in a dominant
negative manner in muscle cells where it blocked myogenic
differentiation and inhibited expression of myogenin and
myosin heavy chain genes (Ornatsky et al. 1997) and in P19
cells where it induced apoptosis and inhibited neurogenesis
(Okamoto et al. 2000). Contrary to our expectations, the
dominant negative MEF2 inhibitor MEF2DN did not inhibit
Nur77 induction by depolarization but in fact augmented it
(Fig. 2b). In the presence of MEF2DN Nur77 induction by
depolarization was more than doubled to 213.97 ± 28.35%
of the KCl response in the presence of a vector control
plasmid (Fig. 2b). MEF2DN expression also increased basal
Nur77 expression in the absence of depolarization by
94.12 ± 24.53% (Fig. 2b). To rule out the possibility that
MEF2DN is unable to act in a dominant negative manner
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Fig. 2 Depolarization-induced Nur77 expression in PC12 cells is
regulated by CREB and modulated by MEF2. (a) Membrane depo-
larization of PC12 cells induces CREB phosphorylation on serine 133.
PC12 cells grown on 35 mm dishes were left untreated (Un) or stim-
ulated with 50 mM extracellular KCl (KCl) for 20 min and processed
for immunoblotting using an antibody that recognizes CREB phos-
phorylated on serine 133 (top panel). Blots were then stripped and
probed with an antibody towards b-actin to control for protein loading
(bottom panel). (b) )1800Nur77Luc expression is inhibited by a
dominant interfering mutant of CREB (A-CREB) but enhanced by
dominant interfering form of MEF2 (MEF2DN). PC12 cells grown
on 12-well cell culture plates were transfected with 500 ng
)1800Nur77Luc, 50 ng phRL-SV40 and 1 lg of the indicated domi-
nant negative CREB or MEF2 expression vector. Thirty-six hours after
transfection, cells were depolarized with 50 mM extracellular KCl for
6 h, and then lysed for luciferase assays. Firefly luciferase activity was
normalized to renilla luciferase activity. The mean ± SEM of relative
luciferase activity is shown in the graph as a percentage of the KCl
response, data were generated from four independent transfection
experiments. (c) MEF2DN inhibits the activation of )1800Nur77Luc
induction by constitutively active MEF2 (MEF2VP16). PC12 cells were
transfected with 1 lg MEF2VP16, 500 ng )1800Nur77Luc, 50 ng
phRL-SV40 and 1 lg of either the vector or MEF2DN expression
plasmid. Luciferase activity was determined 36 h after transfection as
described for (b). Data shown are from six independent experiments.
*p < 0.05 (one-way ANOVA followed by Bonfferroni’s post-hoc test).
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because of an inability to bind DNA and compete with
endogenous MEF2 factors, we tested the effect of MEF2DN
on MEF2VP16-mediated increases in Nur77 expression.
Figure 2(c) shows that co-expression of MEF2DN reduced
MEF2VP16 induced )1800Nur77Luc expression to 11.78 ±
3.30%. Thus, MEF2DN inhibits the ability of MEF2VP16
to activate )1800Nur77Luc expression.
The lack of inhibition by MEF2DN may be explained by
the fact that although it can recruit transcriptional repressors
and does not have the C-terminal transactivation domain it
also lacks the region of MEF2 that is controlled negatively
by a post-translational modiﬁcation with small ubiquitin-
related modiﬁer (SUMO). Sumoylation of MEF2A, C and D
has been documented and interferes with the transcriptional
activity of all three isoforms (Gregoire et al. 2006; Kang
et al. 2006; Shalizi et al. 2006). We hypothesized that
MEF2DN prevents binding of endogenous MEF2s that can
be sumoylated and is therefore competing for the repressive
effects of MEF2 on the Nur77 promoter. To test this
hypothesis we assessed the effects of a SUMO-resistant
mutant of MEF2D where the lysine residue at position 439
that would normally be sumoylated is mutated to an alanine.
Figure 3(a) shows that a MEF2DK439A mutant acts in a
similar fashion to MEF2DN in augmenting basal and
depolarization-induced expression of )1800Nur77Luc.
MEF2DN and the SUMO-resistant mutant MEF2DK439A
also had similar effects on VP16CREB-induced expression
of Nur77 (Fig. 3b). Sumoylation of MEF2D on lysine 439
requires its phosphorylation on serine 444 (Gregoire et al.
2006). Increases in intracellular Ca2+ induce a calcineurin-
dependent dephosphorylation of serine 444 to promote a
switch from sumoylation to acetylation on lysine 439,
resulting in a relief of sumoylation-mediated repression of
MEF2D. Western blot analysis of MEF2D in unstimulated
and depolarized PC12 cells revealed that depolarization alters
the mobility of MEF2D in a manner that would be consistent
with its dephosphorylation (Fig. 3c, compare lanes 1 and 2
and lanes 4 and 5). The change in MEF2D mobility was
observed only after depolarization and not by nerve growth
factor stimulation of PC12 cells and was sensitive to the
calcineurin inhibitor cyclosporine A (Fig. 3c). This suggests
that in unstimulated PC12 cells MEF2D is likely to be
sumoylated. We next assessed what consequences a repressor
form of MEF2, such as a sumoylated MEF2 protein, would
have for Nur77 expression when recruited to the Nur77
MEF2 binding sites. We used a mutant MEF2 protein in
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Fig. 3 MEF2 proteins act as repressors through the C-terminal do-
main. (a) The introduction of a sumoylation resistant mutant of MEF2D
(MEF2DK439A) enhances Nur77 expression to a similar extent as
MEF2DN in untreated or depolarized cells. PC12 cells grown on 12-
well cell culture plates were transfected with 500 ng )1800Nur77Luc,
50 ng phRL-SV40 and 1 lg of either MEF2DN or MEF2K439A. Thirty-
six hours after transfection cells were depolarized and lysed for lucif-
erase assays as described in Fig. 2. Data shown in the graph are from
four independent transfection experiments. (b) MEF2K439A and
MEF2DN augment Nur77 expression induced by constitutively active
CREB (VP16CREB). PC12 cells were transfected with 500 ng
)1800Nur77Luc, 50 ng phRL-SV40 and 1 lg VP16CREB and 1 lg of
either MEF2DN or MEF2K439A expression plasmid. Luciferase
activity was determined 36 h after transfection. The mean ± SEM of
relative luciferase activity is shown in the graph, data were generated
from three independent experiments. *p < 0.05 (one-way ANOVA fol-
lowed by Bonfferroni’s post-hoc test). (c) MEF2D shows a shift in
mobility consistent with dephosphorylation in depolarized cells, but not
in NGF treated cells (U – Untreated; K – KCl; N – NGF). MEF2D
mobility shift in cells treated with KCl (compare lanes 1 and 2), but not
NGF (compare lanes 1 and 3) can be detected as early as 5 min after
treatment and persists for 1 h (see lanes 4–6). The mobility shift is
restored by pre-treatment (10 min) with 100 nM of the calcineurin
inhibitor cyclosporine A (CSA; lanes 7–9). PC12 cells cultured in
35 mm dishes were treated with 50 mM KCl or 100 ng/mL NGF, with
or without 100 nM CSA as indicated. Cells were lysed and protein
harvested at 5 min and 1 h after treatment. MEF2D was detected
using a MEF2D-specific antibody at a dilution of 1 : 2000 (BD Phar-
mingen) and HRP conjugated anti-mouse IgG antibody at 1 : 1000
dilution (Dako).
 2010 The Authors
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which the MADS/MEF2 domain was fused to the transcrip-
tional repressor Engrailed (MEF2-EN). Expression of MEF2-
EN signiﬁcantly attenuated (by 40.80 ± 9.89%) the induction
of )1800Nur77Luc by depolarization (Fig. 4).
Our data thus far support the hypothesis that MEF2DN
potentiates Nur77 expression because it contains only the
MADS/MEF2 domain of MEF2D and thus is not subject to
sumoylation, therefore lacking the ability to repress Nur77
transcription mediated by other transcription factors such as
CREB. An alternative mechanism by which MEF2DN could
increase Nur77 expression is through binding of the
transcription factor NFAT, which is recruited to the Nur77
promoter through interactions with the MADS/MEF2
domain of MEF2 family members (Blaeser et al. 2000;
Kim et al. 2005). Calcineurin regulates NFAT activation by
dephosphorylation of NFAT proteins in the cytoplasm
allowing their translocation to the nucleus. To test for the
involvement of NFAT in the potentiating effects of MEF2DN
we used VIVIT, a potent peptide inhibitor that interacts with
the calcineurin docking site of NFAT proteins and thus
disrupts binding of calcineurin to NFAT, preventing nuclear
translocation of all NFAT isoforms (Aramburu et al. 1999).
Figure 5(a) shows that in PC12 cells transfected with a
plasmid encoding GFP tagged VIVIT, depolarization-in-
duced Nur77 expression was inhibited by 51.84 ± 2.96%.
This decrease in depolarization-induced Nur77 expression by
VIVIT was partially rescued by co-transfection of MEF2DN
(Fig. 5a, compare Nur77 expression in MEF2DN and VIVIT
transfected cells with those transfected with VIVIT alone).
While the decrease in the KCl-induced response by VIVIT is
consistent with previous work that has implicated NFAT
factors in Nur77 transcriptional induction (Blaeser et al.
2000), the rescue by MEF2DN in the presence of VIVIT
suggests that MEF2DN is enhancing Nur77 expression by an
NFAT-independent manner because NFAT is unlikely to be
present in the nucleus when VIVIT is expressed. An NFAT-
independent mechanism for the potentiating effects of
MEF2DN is also supported by the enhancement of basal
Nur77 expression by MEF2DN because under basal condi-
tions NFAT is localized exclusively to the cytoplasm of PC12
cells (Fig. 5b, top panel). This raises questions about the
transcription factor(s) mediating MEF2DN-dependent Nur77
expression under basal conditions. We tested whether this
could be because of the derepression of MEF2-mediated
inhibition of CREB activity under basal conditions.
Figure 6(a) shows that the potentiating effect of MEF2DN
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Fig. 4 Depolarization-induced Nur77 expression is inhibited by an
engineered MEF2 repressor. PC12 cells grown on 12-well cell culture
plates were transfected with 500 ng )1800Nur77Luc, 50 ng phRL-
SV40 and 1 lg of either vector or MEF2-Engrailed (MEF2-EN)
expression plasmid. Thirty-six hours after transfection, cells were
depolarized with 50 mM KCl for 6 h, and then lysed for luciferase
assays. The mean ± SEM of relative luciferase activity is shown in the
graph, data were generated from three independent transfection
experiments. *p < 0.05 (one-way ANOVA followed by Bonfferroni’s
post-hoc test).
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Fig. 5 MEF2DN-mediated enhancement of Nur77 expression can
occur in the absence of nuclear NFAT. (a) MEF2DN rescues VIVIT-
mediated inhibition of KCl-induced Nur77 expression. PC12 cells
cultured in 12-well plates were transfected with )1800Nur77Luc,
phRL-SV40 together with either pcDNA3.1 (vector control), VIVIT,
MEF2DN or VIVIT and MEF2DN. Thirty-six hours after transfection
cells were depolarized with 50 mM KCl for 6 h and the lysates sub-
jected to luciferase assays as described for Fig. 2. Data were gener-
ated from three independent transfection experiments. *p < 0.05 (one-
way ANOVA followed by Bonfferroni’s post-hoc test). (b) NFAT locali-
zation is regulated by depolarization in PC12 cells. Example of cyto-
plasmic expression of GFP-NFAT4 (green) in unstimulated PC12 cell
(upper panel), and translocation into the nucleus in the presence of
KCl (lower panel). PC12 cells cultured on 13 mm coverslips were
transfected with 1 lg GFP-NFAT4 and 24 h after transfection, cells
were either left untreated or stimulated with 50 mM KCl for 45 min.
Cells were then fixed and nuclear stained with Hoechst 33342 (Cyan).
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on basal Nur77 transcription is hampered by co-expression of
dominant negative CREB supporting the notion that under
basal conditions MEF2 factors act to constrain CREB-
mediated gene expression. Similarly, MEF2VP16-mediated
Nur77 expression was also inhibited by A-CREB (Fig. 6b).
Taken together, our data suggest that in PC12 cells CREB
is necessary for activation of Nur77 transcription in response
to depolarization, while MEF2 proteins are required for the
repression of Nur77 in quiescent cells that is relieved by
Ca2+-dependent signaling mechanisms when cells are stim-
ulated. As the PC12 cells used in the experiments above are
undifferentiated cells, we tested whether MEF2DN could
enhance expression of the Nur77 reporter gene in terminally
differentiated primary hippocampal neurons. Figure 7 shows
that MEF2DN boosts expression of the Nur77 reporter in
unstimulated neurons by 817.47 ± 52.01% as well as in
depolarized hippocampal neurons (423.45 ± 31.73%) These
ﬁndings suggest that similar to PC12 cells MEF2 factors are
required for transcriptional repression of Nur77 in unstim-
ulated hippocampal neurons.
Discussion
We have shown here that while Nur77 expression can be
induced by constitutively active mutants of either CREB or
MEF2 transcription factors, only a dominant interfering form
of CREB, but not MEF2, abolishes Nur77 induction by
membrane depolarization indicating that CREB is an essen-
tial mediator of Ca2+-activated Nur77 expression in PC12
cells. The MEF2 dominant negative mutant used here
encodes the MADS/MEF2 domain of mouse MEF2D that
mediates DNA binding and is highly conserved amongst the
four MEF2 family members and between rat, mouse and
human species. MEFDN lacks the C-terminal transactivation
domain, which mediates MEF2 activation in response to p38
MAPK, extracellular signal-regulated kinase 5, and extracel-
lular signal-regulated kinase 1/2 signaling cascades (Mao
et al. 1999; Zhao et al. 1999; Okamoto et al. 2000; Liu et al.
2003; Shalizi et al. 2003; Wang et al. 2007). Because of the
conserved nature of the MADS/MEF2 domain the MEF2DN
protein used here is expected to interfere with the function of
all four MEF2 family members and the dominant interfering
effect of the MADS/MEF2 domain on MEF2-mediated gene
expression has previously been documented (Ornatsky et al.
1997). The lack of inhibition by MEF2DN on depolarization-
induced Nur77 expression in PC12 cells suggests that the C-
terminal domains of MEF2 transcription factors are not
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Fig. 6 MEF2DN-mediated and MEF2VP16-mediated potentiation of
Nur77 expression requires CREB. (a) Co-transfection of A-CREB with
MEF2DN abolished the potentiating effect of MEF2DN on Nur77 gene
expression in unstimulated PC12 cells. (b) A-CREB also attenuated
the activation of Nur77 gene expression mediated by MEF2VP16.
PC12 cells grown on 12-well cell culture plate were co-transfected with
500 ng )1800Nur77Luc, 50 ng phRL-SV40 and 1 lg of either
MEF2DN (a) or MEF2VP16 (b) with or without A-CREB. Thirty-six
hours after transfection, cells were depolarized with 50 mM KCl for
6 h, and then lysed for luciferase assays. The mean ± SEM of relative
luciferase activity is shown in the graph, data were generated from
three independent transfection experiments. *p < 0.05 (one-way
ANOVA followed by Bonfferroni’s post-hoc test).
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Fig. 7 MEF2DN enhances Nur77 expression in primary hippocampal
neurons. MEF2DN induced Nur77 gene expression by more than
eightfold in unstimulated rat hippocampal neurons. It also significantly
enhanced the response induced by KCl. Primary rat hippocampal
neurons were cultured on 12-well cell culture plate and were co-
transfected with 1 lg MEF2DN, 500 ng )1800Nur77Luc and 50 ng
phRL-SV40. Twelve hours after transfection, cells were depolarized
with 40 mM KCl for 4 h, and then lysed for luciferase assays. The
mean ± SEM of relative luciferase activity is shown in the graph, data
were generated from three independent transfection experiments.
*p < 0.05 (one-way ANOVA followed by Bonfferroni’s post-hoc test).
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necessary for Ca2+-activated transcription of the gene. This is
consistent with earlier work from our laboratory where we
reported a robust Ca2+-activated expression of a Gal4 driven
luciferase reporter gene by a full length Gal4MEF2D fusion
protein but not by Gal4MEF2D(C) that contains only the C-
terminal domain of MEF2D (Belﬁeld et al. 2006). Taken
together, this suggests that the C-terminal domain of MEF2D
is neither necessary nor sufﬁcient for Ca2+-activated tran-
scription. The ﬁnding that MEF2DN enhances basal and
depolarization-induced Nur77 expression is consistent with
the previously reported repressive functions of MEF2
proteins that require sumoylation of the C-terminal region
(Gregoire et al. 2006; Shalizi et al. 2006). However,
MEF2DN would be expected to interact with transcriptional
corepressors such as Cabin1 and Class IIa HDACs, HDAC4,
5 and 7 and with transcriptional activators such as NFAT that
further recruits p300 (Kim et al. 2005). The ability of
MEF2DN to enhance Nur77 expression does not however
depend on the recruitment of NFAT as MEF2DN is able to
potentiate Nur77 expression under conditions where NFAT is
cytoplasmic in PC12 cells. The ability of MEF2DN to
enhance Nur77 expression under basal conditions in PC12
cells does however depend on CREB activity as it is blocked
by A-CREB, the dominant negative CREB mutant. Our
ﬁnding that the ability of MEF2DN to enhance Nur77
expression is not restricted to undifferentiated PC12 cells but
also occurs in terminally differentiated hippocampal neurons
suggests that modulation of Nur77 expression by MEF2
factors may affect many cellular processes such as hormone
secretion and differentiation that are triggered by membrane-
depolarization.
Our data thus support the idea that while CREB is
necessary to activate Nur77 transcription, MEF2 functions
mainly as a repressor in unstimulated or non-depolarized
PC12 cells and hippocampal neurons to restrain CREB-
mediated expression of Nur77. This hypothesis is consistent
with the ﬁnding that Nur77 expression in PC12 cells in
response to Ca2+ signals is calcineurin sensitive (Enslen and
Soderling 1994). Calcineurin controls both MEF2 and CREB
transcription factors. For MEF2 factors, calcineurin activity
is required for their derepression by de-sumoylation (Flavell
et al. 2006; Gregoire et al. 2006; Shalizi et al. 2006) and for
subsequent recruitment of NFAT and p300 (Youn et al.
2000). CREB activation is controlled by calcineurin via
recruitment of the CREB coactivators transducers of regu-
lated CREB activities that enhance CRE-dependent tran-
scription through interactions with the basic leucine zipper
DNA binding/dimerization domain of CREB (Conkright
et al. 2003) where calcineurin activity is required for Ca2+-
dependent nuclear localization of transducers of regulated
CREB activities (Bittinger et al. 2004). Many other depo-
larization-induced CREB target genes have functional MEF2
binding sites, and the mechanism proposed here is likely to
have relevance to their regulation as well (Flavell et al.
2008). Examples of such genes are the NR4A family member
Nor-1 (Flavell et al. 2008; Lam et al. 2009), the prototypical
immediate early gene c-fos (Flavell et al. 2008; Maruthappu,
and Chawla, unpublished observations), and brain derived
neurotrophic factor (Flavell et al. 2008). We propose that
MEF2 proteins may function to enhance the signal-to-noise
ratio of the expression of such genes in response to Ca2+
signals. During basal activity MEF2 factors act as active
repressors, preventing the unnecessary expression of MRE-
containing genes by CREB in response to low levels of Ca2+.
Once Ca2+ levels exceed a given threshold in response to
depolarization, MEF2-mediated repression is relieved and
activation of transcription via CREB allows the gene to be
expressed. Further work will reveal whether transcriptional
repression by MEF2 proteins does enhance the signal-to-
noise ratio of gene expression.
Acknowledgements
We thank Dr Xiang-Jiao Yang and Profs David Ginty, Talal Chatila,
Frank McKeon, Anjana Rao, Ilona Skerjanc and Hilmar Bading for
providing plasmid constructs. This work was supported by the
BBSRC (Grant 8/JF/20603) and the Royal Society. SC is a David
Phillips Research Fellow, HLR is a Royal Society University
Research Fellow and BYHL was supported by the Cambridge
Overseas Trust.
References
Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D. D. and Vinson C.
(1998) A dominant-negative inhibitor of CREB reveals that it is a
general mediator of stimulus-dependent transcription of c-fos. Mol.
Cell. Biol. 18, 967–977.
Aramburu J., Yaffe M. B., Lo´pez-Rodrı´guez C., Cantley L. C., Hogan
P. G. and Rao A. (1999) Afﬁnity-driven peptide selection of an
NFAT inhibitor more selective than cyclosporin A. Science 285,
2129–2133.
Belﬁeld J. L., Whittaker C., Cader M. Z. and Chawla S. (2006) Dif-
ferential effects of Ca2+ and cAMP on transcription mediated by
MEF2D and cAMP-response element-binding protein in hippo-
campal neurons. J. Biol. Chem. 281, 27724–27732.
Bittinger M. A., McWhinnie E., Meltzer J., Iourgenko V., Latario B., Liu
X., Chen C. H., Song C., Garza D. and Labow M. (2004) Acti-
vation of cAMP response element-mediated gene expression by
regulated nuclear transport of TORC proteins. Curr. Biol. 14,
2156–2161.
Blaeser F., Ho N., Prywes R. and Chatila T. A. (2000) Ca2+-dependent
gene expression mediated by MEF2 transcription factors. J. Biol.
Chem. 275, 197–209.
Conkright M. D., Canettieri G., Screaton R., Guzman E., Miraglia L.,
Hogenesch J. B. and Montminy M. (2003) TORCs: transducers of
regulated CREB activity. Mol. Cell 12, 413–423.
Dickey C. A., De Mesquita D. D., Morgan D. and Pennypacker K. R.
(2004) Induction of memory-associated immediate early genes by
nerve growth factor in rat primary cortical neurons and differen-
tiated mouse Neuro2A cells. Neurosci. Lett. 366, 10–14.
Enslen H. and Soderling T. R. (1994) Roles of calmodulin-dependent
protein kinases and phosphatase in calcium-dependent transcrip-
tion of immediate early genes. J. Biol. Chem. 269, 20872–20877.
Journal Compilation  2010 International Society for Neurochemistry, J. Neurochem. (2010) 112, 1065–1073
 2010 The Authors
1072 | B. Y. H. Lam et al.
Fass D. M., Butler J. E. and Goodman R. H. (2003) Deacetylase activity
is required for cAMP activation of a subset of CREB target genes.
J. Biol. Chem. 278, 43014–43019.
Flavell S. W., Cowan C. W., Kim T. K., Greer P. L., Lin Y., Paradis S.,
Grifﬁth E. C., Hu L. S., Chen C. and Greenberg M. E. (2006)
Activity-dependent regulation of MEF2 transcription factors
suppresses excitatory synapse number. Science 311, 1008–
1012.
Flavell S. W., Kim T. K., Gray J. M., Harmin D. A., Hemberg M., Hong
E. J., Markenscoff-Papadimitriou E., Bear D. M. and Greenberg
M. E. (2008) Genome-wide analysis of MEF2 transcriptional
program reveals synaptic target genes and neuronal activity-
dependent polyadenylation site selection. Neuron 60, 1022–1038.
Gregoire S., Tremblay A. M., Xiao L., Yang Q., Ma K., Nie J., Mao Z.,
Wu Z., Giguere V. and Yang X. J. (2006) Control of MEF2 tran-
scriptional activity by coordinated phosphorylation and sumoyla-
tion. J. Biol. Chem. 281, 4423–4433.
Impey S., McCorkle S. R., Cha-Molstad H., Dwyer J. M., Yochum G. S.,
Boss J. M., McWeeney S., Dunn J. J., Mandel G. and Goodman
R. H. (2004) Deﬁning the CREB regulon: a genome-wide analysis
of transcription factor regulatory regions. Cell 119, 1041–
1054.
Kang J., Gocke C. B. and Yu H. (2006) Phosphorylation-facilitated su-
moylation of MEF2C negatively regulates its transcriptional
activity. BMC Biochem. 7, 5.
Kendall G., Ensor E., Brar-Rai A., Winter J. and Latchman D. S. (1994)
Nerve growth factor induces expression of immediate-early genes
NGFI-A (Egr-1) and NGFI-B (nur 77) in adult rat dorsal root
ganglion neurons. Brain Res. Mol. Brain Res. 25, 73–79.
Kim H., Lee J. E., Kim B. Y., Cho E. J., Kim S. T. and Youn H. D.
(2005) Menin represses JunD transcriptional activity in protein
kinase C theta-mediated Nur77 expression. Exp. Mol. Med. 37,
466–475.
Lam B. Y. and Chawla S. (2007) MEF2D expression increases during
neuronal differentiation of neural progenitor cells and correlates
with neurite length. Neurosci. Lett. 427, 153–158.
Lam B. Y., Zhang W., Enticknap N., Haggis E., Cader M. Z. and Chawla
S. (2009) Inverse regulation of plasticity-related immediate early
genes by calcineurin in hippocampal neurons. J. Biol. Chem. 284,
12562–12571.
Liu L., Cavanaugh J. E., Wang Y., Sakagami H., Mao Z. and Xia Z. (2003)
ERK5 activation of MEF2-mediated gene expression plays a critical
role in BDNF-promoted survival of developing but not mature cor-
tical neurons. Proc. Natl Acad. Sci. USA 100, 8532–8537.
Machado H. B., Vician L. J. and Herschman H. R. (2008) The MAPK
pathway is required for depolarization-induced ‘‘promiscuous’’
immediate-early gene expression but not for depolarization re-
stricted immediate-early gene expression in neurons. J. Neurosci.
Res. 86, 593–602.
Mao Z., Bonni A., Xia F., Nadal-Vicens M. and Greenberg M. E. (1999)
Neuronal activity-dependent cell survival mediated by transcription
factor MEF2. Science 286, 785–790.
Maxwell M. A. and Muscat G. E. (2006) The NR4A subgroup: imme-
diate early response genes with pleiotropic physiological roles.
Nucl. Recept. Signal. 4, e002.
Milbrandt J. (1988) Nerve growth factor induces a gene homologous to
the glucocorticoid receptor gene. Neuron 1, 183–188.
Okamoto S., Krainc D., Sherman K. and Lipton S. A. (2000) Antia-
poptotic role of the p38 mitogen-activated protein kinase-myocyte
enhancer factor 2 transcription factor pathway during neuronal
differentiation. Proc. Natl Acad. Sci. USA 97, 7561–7566.
Ornatsky O. I., Andreucci J. J. and McDermott J. C. (1997) A dominant-
negative form of transcription factor MEF2 inhibits myogenesis.
J. Biol. Chem. 272, 33271–33278.
Shalizi A., Lehtinen M., Gaudilliere B., Donovan N., Han J., Konishi Y.
and Bonni A. (2003) Characterization of a neurotrophin signaling
mechanism that mediates neuron survival in a temporally speciﬁc
pattern. J. Neurosci. 23, 7326–7336.
Shalizi A., Gaudilliere B., Yuan Z., Stegmuller J., Shirogane T., Ge Q.,
Tan Y., Schulman B., Harper J. W. and Bonni A. (2006) A calcium-
regulated MEF2 sumoylation switch controls postsynaptic differ-
entiation. Science 311, 1012–1017.
Wang Y., Liu L. and Xia Z. (2007) Brain-derived neurotrophic factor
stimulates the transcriptional and neuroprotective activity of
myocyte-enhancer factor 2C through an ERK1/2-RSK2 signaling
cascade. J. Neurochem. 102, 957–966.
Woronicz J. D., Lina A., Calnan B. J., Szychowski S., Cheng L. and
Winoto A. (1995) Regulation of the Nur77 orphan steroid
receptor in activation-induced apoptosis. Mol. Cell. Biol. 15,
6364–6376.
Yoon J. K. and Lau L. F. (1993) Transcriptional activation of the inducible
nuclear receptor gene nur77 by nerve growth factor and membrane
depolarization in PC12 cells. J. Biol. Chem. 268, 9148–9155.
Yoon J. K. and Lau L. F. (1994) Involvement of JunD in transcriptional
activation of the orphan receptor gene nur77 by nerve growth
factor and membrane depolarization in PC12 cells. Mol. Cell. Biol.
14, 7731–7743.
Youn H. D., Chatila T. A. and Liu J. O. (2000) Integration of calcineurin
and MEF2 signals by the coactivator p300 during T-cell apoptosis.
EMBO J. 19, 4323–4331.
Zhang S. J., Steijaert M. N., Lau D., Schutz G., Delucinge-Vivier C.,
Descombes P. and Bading H. (2007) Decoding NMDA receptor
signaling: identiﬁcation of genomic programs specifying neuronal
survival and death. Neuron 53, 549–562.
Zhao M., New L., Kravchenko V. V., Kato Y., Gram H., di Padova F.,
Olson E. N., Ulevitch R. J. and Han J. (1999) Regulation of the
MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19,
21–30.
 2010 The Authors
Journal Compilation  2010 International Society for Neurochemistry, J. Neurochem. (2010) 112, 1065–1073
MEF2 modulates CREB-dependent Nur77 expression | 1073
